Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepacivirus | 82 | 2023 | 1330 | 7.470 |
Why?
|
Hepatitis C | 81 | 2023 | 1579 | 6.400 |
Why?
|
CD8-Positive T-Lymphocytes | 42 | 2023 | 4574 | 2.860 |
Why?
|
Hepatitis C, Chronic | 25 | 2023 | 1027 | 2.410 |
Why?
|
Hepatitis B, Chronic | 9 | 2024 | 410 | 2.040 |
Why?
|
CD4-Positive T-Lymphocytes | 19 | 2022 | 4372 | 1.870 |
Why?
|
Hepatitis B | 8 | 2024 | 703 | 1.590 |
Why?
|
Hepatitis B virus | 10 | 2024 | 527 | 1.510 |
Why?
|
Substance Abuse, Intravenous | 11 | 2020 | 529 | 1.060 |
Why?
|
Immunologic Memory | 6 | 2021 | 1361 | 0.790 |
Why?
|
Epitopes, T-Lymphocyte | 21 | 2019 | 822 | 0.760 |
Why?
|
Antiviral Agents | 16 | 2023 | 3048 | 0.760 |
Why?
|
Viral Nonstructural Proteins | 13 | 2016 | 227 | 0.670 |
Why?
|
HLA-B Antigens | 5 | 2017 | 317 | 0.630 |
Why?
|
Viral Vaccines | 4 | 2014 | 593 | 0.630 |
Why?
|
Epitopes | 5 | 2021 | 2504 | 0.620 |
Why?
|
Hepatitis A | 1 | 2019 | 127 | 0.610 |
Why?
|
Hepatitis C Antibodies | 8 | 2019 | 147 | 0.600 |
Why?
|
Liver | 14 | 2024 | 7514 | 0.580 |
Why?
|
Virus Replication | 7 | 2023 | 2426 | 0.510 |
Why?
|
Gastroenterology | 1 | 2022 | 580 | 0.510 |
Why?
|
RNA, Viral | 17 | 2022 | 2839 | 0.500 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7571 | 0.480 |
Why?
|
Acute Disease | 18 | 2022 | 7226 | 0.480 |
Why?
|
Interferons | 8 | 2020 | 702 | 0.410 |
Why?
|
Plastic Embedding | 2 | 2009 | 8 | 0.400 |
Why?
|
Liver Cirrhosis | 8 | 2024 | 1932 | 0.390 |
Why?
|
T-Lymphocytes | 7 | 2019 | 10203 | 0.390 |
Why?
|
Flow Cytometry | 4 | 2019 | 5871 | 0.390 |
Why?
|
Lymphocyte Activation | 11 | 2022 | 5478 | 0.380 |
Why?
|
Haplotypes | 2 | 2020 | 2715 | 0.370 |
Why?
|
Interleukins | 5 | 2018 | 782 | 0.370 |
Why?
|
Antigens, CD | 6 | 2022 | 4009 | 0.360 |
Why?
|
Viral Load | 12 | 2024 | 3328 | 0.350 |
Why?
|
Remission, Spontaneous | 8 | 2022 | 384 | 0.350 |
Why?
|
Genome, Viral | 6 | 2019 | 665 | 0.330 |
Why?
|
Viral Hepatitis Vaccines | 5 | 2019 | 72 | 0.320 |
Why?
|
Paraffin Embedding | 1 | 2009 | 302 | 0.310 |
Why?
|
Immunodominant Epitopes | 5 | 2015 | 237 | 0.300 |
Why?
|
Lectins, C-Type | 4 | 2022 | 585 | 0.290 |
Why?
|
Genotype | 18 | 2022 | 12985 | 0.290 |
Why?
|
HLA-B27 Antigen | 3 | 2013 | 63 | 0.290 |
Why?
|
Killer Cells, Natural | 4 | 2019 | 2194 | 0.290 |
Why?
|
Prisoners | 2 | 2013 | 314 | 0.290 |
Why?
|
HIV Infections | 16 | 2024 | 17347 | 0.280 |
Why?
|
Humans | 129 | 2024 | 761208 | 0.280 |
Why?
|
Prisons | 1 | 2009 | 174 | 0.280 |
Why?
|
Antigens, Differentiation | 1 | 2009 | 918 | 0.270 |
Why?
|
T-Box Domain Proteins | 4 | 2016 | 469 | 0.250 |
Why?
|
Disease Transmission, Infectious | 2 | 2019 | 561 | 0.250 |
Why?
|
Immunity, Cellular | 3 | 2007 | 1553 | 0.240 |
Why?
|
Viremia | 6 | 2012 | 707 | 0.220 |
Why?
|
Adaptive Immunity | 2 | 2019 | 724 | 0.220 |
Why?
|
Hepatic Stellate Cells | 1 | 2024 | 119 | 0.220 |
Why?
|
Antibodies, Neutralizing | 4 | 2019 | 1935 | 0.220 |
Why?
|
Drug Users | 4 | 2019 | 134 | 0.210 |
Why?
|
Phylogeny | 9 | 2019 | 2809 | 0.210 |
Why?
|
Immune Evasion | 2 | 2017 | 364 | 0.210 |
Why?
|
Drug Resistance, Viral | 3 | 2016 | 862 | 0.200 |
Why?
|
Antigens, Surface | 2 | 2022 | 1607 | 0.200 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1141 | 0.200 |
Why?
|
Antigens, Viral | 3 | 2021 | 989 | 0.200 |
Why?
|
Histocompatibility Antigens Class II | 3 | 2019 | 1435 | 0.200 |
Why?
|
Interferon-alpha | 4 | 2019 | 907 | 0.190 |
Why?
|
Peroxidases | 1 | 2022 | 134 | 0.190 |
Why?
|
Hepatitis C Antigens | 3 | 2015 | 34 | 0.190 |
Why?
|
Lymphocytic Choriomeningitis | 3 | 2016 | 139 | 0.190 |
Why?
|
Male | 60 | 2024 | 360693 | 0.190 |
Why?
|
HIV-1 | 6 | 2017 | 6851 | 0.190 |
Why?
|
T-Lymphocyte Subsets | 3 | 2015 | 1803 | 0.180 |
Why?
|
Female | 63 | 2024 | 392544 | 0.180 |
Why?
|
Adult | 48 | 2024 | 221119 | 0.180 |
Why?
|
Immunity, Innate | 3 | 2019 | 3044 | 0.180 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2022 | 897 | 0.180 |
Why?
|
Immunotherapy | 3 | 2016 | 4642 | 0.170 |
Why?
|
Middle Aged | 36 | 2024 | 220853 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2022 | 15920 | 0.170 |
Why?
|
Ribavirin | 4 | 2021 | 394 | 0.170 |
Why?
|
Zambia | 3 | 2024 | 271 | 0.160 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2019 | 1348 | 0.160 |
Why?
|
Bone and Bones | 1 | 2009 | 2568 | 0.160 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2019 | 71 | 0.160 |
Why?
|
Phenotype | 6 | 2021 | 16575 | 0.160 |
Why?
|
T-Cell Antigen Receptor Specificity | 3 | 2015 | 84 | 0.160 |
Why?
|
Natural Killer T-Cells | 1 | 2022 | 322 | 0.150 |
Why?
|
Cell Differentiation | 9 | 2021 | 11509 | 0.150 |
Why?
|
Major Histocompatibility Complex | 2 | 2018 | 872 | 0.150 |
Why?
|
Mouth Mucosa | 1 | 2001 | 432 | 0.150 |
Why?
|
Fatty Liver | 1 | 2024 | 789 | 0.150 |
Why?
|
Color | 1 | 2019 | 297 | 0.150 |
Why?
|
Amino Acid Substitution | 3 | 2022 | 1737 | 0.140 |
Why?
|
Young Adult | 18 | 2024 | 59221 | 0.140 |
Why?
|
Receptors, KIR3DL1 | 1 | 2017 | 26 | 0.140 |
Why?
|
Models, Immunological | 1 | 2019 | 515 | 0.140 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 3 | 2014 | 84 | 0.140 |
Why?
|
Interferon-gamma | 7 | 2020 | 3155 | 0.140 |
Why?
|
Proline | 4 | 2022 | 455 | 0.140 |
Why?
|
Sex Factors | 3 | 2021 | 10553 | 0.140 |
Why?
|
Viral Envelope Proteins | 2 | 2019 | 639 | 0.140 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 834 | 0.130 |
Why?
|
RNA Virus Infections | 1 | 2015 | 19 | 0.130 |
Why?
|
Parturition | 1 | 2020 | 447 | 0.130 |
Why?
|
Host-Pathogen Interactions | 2 | 2022 | 1448 | 0.130 |
Why?
|
Alanine Transaminase | 4 | 2022 | 602 | 0.130 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2011 | 1783 | 0.130 |
Why?
|
Receptors, Fc | 1 | 2019 | 537 | 0.130 |
Why?
|
HLA Antigens | 3 | 2013 | 1331 | 0.130 |
Why?
|
Interleukin-18 | 1 | 2017 | 250 | 0.120 |
Why?
|
Uridine Monophosphate | 1 | 2015 | 66 | 0.120 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 2 | 2014 | 29 | 0.120 |
Why?
|
Protease Inhibitors | 2 | 2009 | 752 | 0.120 |
Why?
|
B-Lymphocyte Subsets | 1 | 2016 | 238 | 0.120 |
Why?
|
Th1 Cells | 1 | 2020 | 1042 | 0.120 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 2 | 2014 | 95 | 0.120 |
Why?
|
Cryoglobulins | 1 | 2014 | 58 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 3 | 2019 | 1838 | 0.120 |
Why?
|
Staining and Labeling | 1 | 2019 | 1080 | 0.120 |
Why?
|
Chronic Disease | 8 | 2019 | 9319 | 0.120 |
Why?
|
Fluorenes | 1 | 2015 | 157 | 0.120 |
Why?
|
Up-Regulation | 3 | 2021 | 4111 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1812 | 0.120 |
Why?
|
Gene Expression | 3 | 2022 | 7571 | 0.110 |
Why?
|
Bystander Effect | 1 | 2014 | 89 | 0.110 |
Why?
|
Cytokines | 6 | 2022 | 7386 | 0.110 |
Why?
|
Interferon Type I | 1 | 2017 | 557 | 0.110 |
Why?
|
CA-125 Antigen | 1 | 2016 | 281 | 0.110 |
Why?
|
Cell Culture Techniques | 2 | 2019 | 1662 | 0.110 |
Why?
|
Aged | 21 | 2024 | 169288 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2451 | 0.110 |
Why?
|
Viral Proteins | 5 | 2019 | 1798 | 0.110 |
Why?
|
Cross Infection | 2 | 2015 | 1422 | 0.110 |
Why?
|
Apyrase | 1 | 2015 | 373 | 0.100 |
Why?
|
Liver Transplantation | 2 | 2021 | 2332 | 0.100 |
Why?
|
Peptides | 3 | 2019 | 4353 | 0.100 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2007 | 1053 | 0.100 |
Why?
|
Mutation | 11 | 2019 | 30002 | 0.100 |
Why?
|
Polysaccharides | 1 | 2019 | 1014 | 0.100 |
Why?
|
Epidemics | 2 | 2016 | 512 | 0.100 |
Why?
|
Hepatitis B e Antigens | 2 | 2023 | 133 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 3803 | 0.100 |
Why?
|
Aspirin | 1 | 2024 | 3129 | 0.100 |
Why?
|
Bone Substitutes | 1 | 2014 | 233 | 0.100 |
Why?
|
Biopsy | 3 | 2022 | 6781 | 0.100 |
Why?
|
Immunoglobulin G | 3 | 2019 | 4537 | 0.100 |
Why?
|
Genetic Variation | 4 | 2019 | 6567 | 0.100 |
Why?
|
Hepatitis B Surface Antigens | 2 | 2024 | 294 | 0.100 |
Why?
|
Thermus | 1 | 1991 | 10 | 0.100 |
Why?
|
Epitope Mapping | 2 | 2017 | 298 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2024 | 2293 | 0.090 |
Why?
|
DNA Ligases | 1 | 1991 | 82 | 0.090 |
Why?
|
Suppression, Genetic | 1 | 2011 | 190 | 0.090 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2010 | 14 | 0.090 |
Why?
|
Lymphocyte Count | 2 | 2010 | 781 | 0.090 |
Why?
|
Drug Therapy, Combination | 4 | 2019 | 6304 | 0.090 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9187 | 0.090 |
Why?
|
Amino Acid Sequence | 7 | 2017 | 13402 | 0.090 |
Why?
|
DNA, Viral | 4 | 2023 | 2195 | 0.090 |
Why?
|
Fibrosis | 3 | 2022 | 2051 | 0.090 |
Why?
|
Fluorescent Dyes | 1 | 2019 | 1901 | 0.090 |
Why?
|
2-Naphthylamine | 2 | 2021 | 20 | 0.090 |
Why?
|
Receptors, KIR | 1 | 2010 | 110 | 0.090 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2006 | 976 | 0.090 |
Why?
|
Cluster Analysis | 1 | 2017 | 2706 | 0.090 |
Why?
|
HLA-C Antigens | 1 | 2010 | 141 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2015 | 858 | 0.090 |
Why?
|
Interleukin-2 | 2 | 2020 | 1891 | 0.090 |
Why?
|
Vasculitis | 1 | 2014 | 522 | 0.090 |
Why?
|
Osteonectin | 1 | 2009 | 33 | 0.090 |
Why?
|
Placenta | 1 | 2019 | 1711 | 0.090 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2009 | 50 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1360 | 0.080 |
Why?
|
Cohort Studies | 10 | 2019 | 41496 | 0.080 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18220 | 0.080 |
Why?
|
Down-Regulation | 2 | 2021 | 2916 | 0.080 |
Why?
|
Trabecular Meshwork | 1 | 2009 | 101 | 0.080 |
Why?
|
HIV Antibodies | 1 | 2016 | 1301 | 0.080 |
Why?
|
North America | 3 | 2017 | 1284 | 0.080 |
Why?
|
K562 Cells | 1 | 2010 | 640 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1743 | 0.080 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2014 | 501 | 0.080 |
Why?
|
Uracil | 2 | 2021 | 207 | 0.080 |
Why?
|
Biopsy, Fine-Needle | 2 | 2024 | 1118 | 0.080 |
Why?
|
Hemodialysis Units, Hospital | 1 | 2008 | 22 | 0.080 |
Why?
|
Cyclopropanes | 2 | 2021 | 432 | 0.080 |
Why?
|
Cross Reactions | 3 | 2019 | 819 | 0.080 |
Why?
|
Lactams, Macrocyclic | 2 | 2021 | 318 | 0.080 |
Why?
|
Clinical Enzyme Tests | 1 | 2008 | 113 | 0.080 |
Why?
|
Immunity, Mucosal | 1 | 2011 | 485 | 0.080 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4309 | 0.080 |
Why?
|
Virus Diseases | 1 | 2014 | 716 | 0.070 |
Why?
|
Case-Control Studies | 4 | 2014 | 22174 | 0.070 |
Why?
|
Membrane Proteins | 2 | 2016 | 7851 | 0.070 |
Why?
|
Osteopontin | 1 | 2009 | 302 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2150 | 0.070 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 1031 | 0.070 |
Why?
|
Australia | 3 | 2016 | 1246 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3788 | 0.070 |
Why?
|
Tissue Scaffolds | 1 | 2014 | 932 | 0.070 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 1408 | 0.070 |
Why?
|
Hepatocytes | 1 | 2014 | 1231 | 0.070 |
Why?
|
Orthomyxoviridae | 1 | 2008 | 149 | 0.070 |
Why?
|
Antibody Affinity | 2 | 2019 | 246 | 0.070 |
Why?
|
Viral Core Proteins | 1 | 2006 | 158 | 0.070 |
Why?
|
Prospective Studies | 12 | 2024 | 54435 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2016 | 2640 | 0.070 |
Why?
|
Bacterial Infections | 1 | 2014 | 1390 | 0.060 |
Why?
|
Animals | 17 | 2024 | 168079 | 0.060 |
Why?
|
Incidence | 6 | 2018 | 21365 | 0.060 |
Why?
|
HLA-DR Antigens | 2 | 2005 | 606 | 0.060 |
Why?
|
HLA-B8 Antigen | 1 | 2004 | 16 | 0.060 |
Why?
|
Disease Progression | 3 | 2021 | 13511 | 0.060 |
Why?
|
Adolescent | 9 | 2024 | 88298 | 0.060 |
Why?
|
Thioacetamide | 1 | 2024 | 22 | 0.060 |
Why?
|
Th17 Cells | 1 | 2011 | 794 | 0.060 |
Why?
|
Diethylnitrosamine | 1 | 2024 | 45 | 0.060 |
Why?
|
Lymphocytic choriomeningitis virus | 2 | 2016 | 176 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2014 | 1867 | 0.060 |
Why?
|
Carbon Tetrachloride | 1 | 2024 | 72 | 0.060 |
Why?
|
Genome-Wide Association Study | 6 | 2022 | 12676 | 0.060 |
Why?
|
Glycosylation | 2 | 2019 | 1095 | 0.060 |
Why?
|
Macrocyclic Compounds | 2 | 2019 | 68 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2019 | 18926 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12052 | 0.060 |
Why?
|
Tissue Engineering | 1 | 2014 | 1865 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2009 | 11067 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9416 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2016 | 4027 | 0.060 |
Why?
|
Recombinant Proteins | 3 | 2010 | 6504 | 0.050 |
Why?
|
Risk-Taking | 1 | 2009 | 1038 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2024 | 64681 | 0.050 |
Why?
|
Time Factors | 5 | 2017 | 39957 | 0.050 |
Why?
|
Collagen | 2 | 2022 | 2635 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2016 | 4744 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2022 | 1695 | 0.050 |
Why?
|
Communicable Disease Control | 1 | 2009 | 846 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2011 | 2567 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3777 | 0.050 |
Why?
|
Hepatitis B Core Antigens | 1 | 2022 | 90 | 0.050 |
Why?
|
Pilot Projects | 3 | 2015 | 8642 | 0.050 |
Why?
|
HLA-A2 Antigen | 1 | 2002 | 209 | 0.050 |
Why?
|
Sequence Analysis, DNA | 4 | 2016 | 4739 | 0.050 |
Why?
|
Brazil | 3 | 2011 | 1228 | 0.050 |
Why?
|
Hepatitis B Antibodies | 1 | 2022 | 155 | 0.050 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22127 | 0.050 |
Why?
|
Septins | 1 | 2021 | 49 | 0.050 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39126 | 0.050 |
Why?
|
Nucleosides | 1 | 2021 | 130 | 0.050 |
Why?
|
High Mobility Group Proteins | 1 | 2021 | 177 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2019 | 3634 | 0.050 |
Why?
|
Massachusetts | 2 | 2015 | 8837 | 0.050 |
Why?
|
Organotechnetium Compounds | 1 | 2000 | 132 | 0.050 |
Why?
|
Palate | 1 | 2001 | 125 | 0.040 |
Why?
|
Leucine | 1 | 2022 | 546 | 0.040 |
Why?
|
Alleles | 3 | 2022 | 6857 | 0.040 |
Why?
|
Sulfonamides | 2 | 2021 | 1977 | 0.040 |
Why?
|
Europe | 2 | 2017 | 3423 | 0.040 |
Why?
|
Basement Membrane | 1 | 2001 | 348 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 1 | 2022 | 380 | 0.040 |
Why?
|
Mice | 8 | 2024 | 81326 | 0.040 |
Why?
|
Mandibular Neoplasms | 1 | 2000 | 130 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2005 | 1187 | 0.040 |
Why?
|
Lipids | 1 | 2011 | 3331 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2001 | 1703 | 0.040 |
Why?
|
End Stage Liver Disease | 1 | 2024 | 352 | 0.040 |
Why?
|
Valine | 1 | 2021 | 408 | 0.040 |
Why?
|
Ritonavir | 1 | 2021 | 329 | 0.040 |
Why?
|
Belgium | 1 | 2019 | 119 | 0.040 |
Why?
|
Keratins | 1 | 2001 | 498 | 0.040 |
Why?
|
Laminin | 1 | 2001 | 407 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12939 | 0.040 |
Why?
|
Genes, MHC Class II | 2 | 2014 | 433 | 0.040 |
Why?
|
Ribosomal Proteins | 1 | 2021 | 370 | 0.040 |
Why?
|
Connective Tissue | 1 | 2001 | 419 | 0.040 |
Why?
|
Molecular Sequence Data | 6 | 2007 | 17598 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2012 | 10422 | 0.040 |
Why?
|
Cell Degranulation | 1 | 2019 | 277 | 0.040 |
Why?
|
Anilides | 1 | 2021 | 411 | 0.040 |
Why?
|
Coloring Agents | 1 | 2001 | 561 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 3726 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8530 | 0.040 |
Why?
|
Gene Frequency | 2 | 2016 | 3603 | 0.040 |
Why?
|
Dengue Virus | 1 | 2019 | 201 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 830 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 619 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15308 | 0.040 |
Why?
|
Chromatin | 2 | 2021 | 2946 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3758 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8003 | 0.030 |
Why?
|
Binding Sites | 2 | 2019 | 5988 | 0.030 |
Why?
|
Phylogeography | 1 | 2016 | 72 | 0.030 |
Why?
|
Keratinocytes | 1 | 2001 | 790 | 0.030 |
Why?
|
Blood Donors | 1 | 2019 | 345 | 0.030 |
Why?
|
Dengue | 1 | 2019 | 254 | 0.030 |
Why?
|
Lost to Follow-Up | 1 | 2017 | 123 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 2013 | 4413 | 0.030 |
Why?
|
Epithelium | 1 | 2001 | 1603 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2019 | 558 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2001 | 2112 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17897 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2006 | 2667 | 0.030 |
Why?
|
Diphosphonates | 1 | 2000 | 634 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2004 | 2196 | 0.030 |
Why?
|
Population Surveillance | 2 | 2017 | 2598 | 0.030 |
Why?
|
Arenaviridae Infections | 1 | 2015 | 53 | 0.030 |
Why?
|
Cell Line | 1 | 2009 | 15545 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 1130 | 0.030 |
Why?
|
Mouth Neoplasms | 1 | 2000 | 596 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2011 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2016 | 286 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2016 | 489 | 0.030 |
Why?
|
Dioxygenases | 1 | 2017 | 346 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 956 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2022 | 1933 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2016 | 470 | 0.030 |
Why?
|
Hydroxyapatites | 1 | 2014 | 73 | 0.030 |
Why?
|
Perforin | 1 | 2014 | 166 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4340 | 0.030 |
Why?
|
Risk Factors | 6 | 2021 | 74239 | 0.030 |
Why?
|
Mucus | 1 | 2016 | 342 | 0.030 |
Why?
|
Rats | 2 | 2024 | 23704 | 0.030 |
Why?
|
Cryoglobulinemia | 1 | 2014 | 84 | 0.030 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2016 | 282 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2022 | 2138 | 0.030 |
Why?
|
Evolution, Molecular | 3 | 2007 | 1882 | 0.030 |
Why?
|
Bone Matrix | 1 | 2014 | 118 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2017 | 1216 | 0.030 |
Why?
|
Ceramics | 1 | 2014 | 113 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 586 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2014 | 368 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16952 | 0.030 |
Why?
|
Interleukin-4 | 1 | 1997 | 1154 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2004 | 2726 | 0.030 |
Why?
|
Antigen Presentation | 2 | 2011 | 1251 | 0.030 |
Why?
|
Alveolar Process | 1 | 2014 | 290 | 0.030 |
Why?
|
Risk Assessment | 2 | 2017 | 24021 | 0.030 |
Why?
|
Antibodies | 1 | 2001 | 2415 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1217 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2016 | 659 | 0.030 |
Why?
|
STAT1 Transcription Factor | 1 | 2014 | 340 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1159 | 0.030 |
Why?
|
Inflammasomes | 1 | 2017 | 526 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2015 | 1535 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2014 | 823 | 0.020 |
Why?
|
Prognosis | 2 | 2013 | 29687 | 0.020 |
Why?
|
Cytomegalovirus | 2 | 2008 | 750 | 0.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 399 | 0.020 |
Why?
|
Interleukin-10 | 1 | 1997 | 1176 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 1991 | 4167 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 1249 | 0.020 |
Why?
|
Maxilla | 1 | 2014 | 486 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2000 | 2683 | 0.020 |
Why?
|
Cell Separation | 1 | 2016 | 1721 | 0.020 |
Why?
|
Biological Evolution | 1 | 2016 | 1075 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13249 | 0.020 |
Why?
|
Genes, p53 | 1 | 1993 | 713 | 0.020 |
Why?
|
Base Sequence | 3 | 2007 | 12404 | 0.020 |
Why?
|
Vagina | 1 | 2016 | 841 | 0.020 |
Why?
|
United States | 5 | 2019 | 72339 | 0.020 |
Why?
|
Genes, ras | 1 | 1993 | 654 | 0.020 |
Why?
|
Sampling Studies | 1 | 2011 | 615 | 0.020 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2014 | 455 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 2 | 2007 | 2569 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12341 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26071 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15520 | 0.020 |
Why?
|
Wound Healing | 1 | 2001 | 2800 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2002 | 5103 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2014 | 743 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2393 | 0.020 |
Why?
|
Phenylthiourea | 1 | 2008 | 10 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2011 | 2549 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2001 | 3671 | 0.020 |
Why?
|
Osteoblasts | 1 | 2014 | 1144 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2017 | 1589 | 0.020 |
Why?
|
HIV | 2 | 2008 | 1581 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2019 | 3149 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2016 | 2329 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14610 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2024 | 4526 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2014 | 14392 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2003 | 4242 | 0.020 |
Why?
|
Netherlands | 1 | 2012 | 2222 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2011 | 643 | 0.020 |
Why?
|
Neuraminidase | 1 | 2008 | 195 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29893 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2548 | 0.020 |
Why?
|
Blotting, Western | 2 | 2011 | 5032 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2468 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2000 | 4052 | 0.020 |
Why?
|
Carbamates | 1 | 2008 | 191 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2125 | 0.020 |
Why?
|
Osteogenesis | 1 | 2014 | 1273 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 2010 | 612 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2010 | 58952 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3369 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5753 | 0.020 |
Why?
|
Genes, MHC Class I | 1 | 2007 | 235 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2008 | 193 | 0.020 |
Why?
|
Consensus Sequence | 1 | 2007 | 362 | 0.020 |
Why?
|
Serotyping | 1 | 2007 | 325 | 0.020 |
Why?
|
Models, Molecular | 1 | 2017 | 5406 | 0.020 |
Why?
|
HIV Core Protein p24 | 1 | 2006 | 244 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 1991 | 1470 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2011 | 675 | 0.020 |
Why?
|
Comorbidity | 2 | 2014 | 10516 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2015 | 1747 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2007 | 251 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2008 | 628 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2019 | 26199 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2000 | 4021 | 0.020 |
Why?
|
Fetal Blood | 1 | 2011 | 1348 | 0.010 |
Why?
|
Temperature | 1 | 1991 | 2219 | 0.010 |
Why?
|
Agammaglobulinemia | 1 | 2006 | 172 | 0.010 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2007 | 330 | 0.010 |
Why?
|
Escherichia coli | 2 | 1991 | 4201 | 0.010 |
Why?
|
Program Evaluation | 1 | 2013 | 2489 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1812 | 0.010 |
Why?
|
Prevalence | 1 | 2001 | 15721 | 0.010 |
Why?
|
Pan troglodytes | 1 | 2004 | 223 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2004 | 317 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2000 | 8998 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9520 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9297 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3805 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6067 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2014 | 1645 | 0.010 |
Why?
|
Oligopeptides | 1 | 2008 | 1179 | 0.010 |
Why?
|
Quinolines | 1 | 2008 | 764 | 0.010 |
Why?
|
Immunoassay | 1 | 2006 | 743 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2007 | 2175 | 0.010 |
Why?
|
Triglycerides | 1 | 2011 | 2457 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5828 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4243 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2007 | 2740 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8300 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2004 | 716 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 2008 | 957 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4513 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14675 | 0.010 |
Why?
|
Cell Count | 1 | 2006 | 1831 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10756 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2380 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3727 | 0.010 |
Why?
|
Thiazoles | 1 | 2008 | 1517 | 0.010 |
Why?
|
Selection, Genetic | 1 | 2006 | 871 | 0.010 |
Why?
|
Amino Acids | 1 | 2007 | 1703 | 0.010 |
Why?
|
Immunoglobulins | 1 | 2004 | 850 | 0.010 |
Why?
|
Infection Control | 1 | 2008 | 983 | 0.010 |
Why?
|
Radiography, Panoramic | 1 | 2000 | 112 | 0.010 |
Why?
|
HeLa Cells | 1 | 2006 | 3073 | 0.010 |
Why?
|
Cell Division | 1 | 2008 | 4451 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2011 | 12747 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1980 | 455 | 0.010 |
Why?
|
Stem Cells | 1 | 2012 | 3517 | 0.010 |
Why?
|
Globins | 1 | 1980 | 405 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2008 | 2220 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6199 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2001 | 800 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 828 | 0.010 |
Why?
|
Mass Screening | 1 | 2013 | 5426 | 0.010 |
Why?
|
Coronary Disease | 1 | 2011 | 5921 | 0.010 |
Why?
|
Genes | 1 | 1980 | 1820 | 0.010 |
Why?
|
Mandible | 1 | 2000 | 744 | 0.010 |
Why?
|
Genetic Testing | 1 | 2008 | 3537 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15841 | 0.010 |
Why?
|
Patient Care Planning | 1 | 2000 | 901 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1993 | 5366 | 0.010 |
Why?
|
Observer Variation | 1 | 2000 | 2610 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12099 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10759 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8457 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3696 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2015 | 80674 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2000 | 3590 | 0.010 |
Why?
|
Th2 Cells | 1 | 1997 | 1071 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2008 | 7400 | 0.010 |
Why?
|
Point Mutation | 1 | 1993 | 1593 | 0.000 |
Why?
|
RNA | 1 | 1997 | 2709 | 0.000 |
Why?
|
Pancreas | 1 | 1993 | 1684 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1993 | 6124 | 0.000 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 1993 | 2915 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1980 | 548 | 0.000 |
Why?
|
Lac Operon | 1 | 1980 | 237 | 0.000 |
Why?
|
beta-Galactosidase | 1 | 1980 | 574 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20588 | 0.000 |
Why?
|
Plasmids | 1 | 1980 | 2261 | 0.000 |
Why?
|
Rabbits | 1 | 1980 | 4750 | 0.000 |
Why?
|